2019

Jul - Dr. Stiles named to NIH/NINDS Special Emphasis Panel

Apr - Phase 1B NIH grant received to develop MS therapeutic


Lauren Anderson

Founder | CEO

Previous
Previous

2020

Next
Next

2018